s6y

S-4 Registration of securities issued in business combination transactions

Filed
Accession number
0001213900-23-046942

Documents

  1. REGISTRATION STATEMENT S-4
  2. CERO THERAPEUTICS, INC. 2016 EQUITY INCENTIVE PLAN, AS AMENDED, AND FORMS OF AWARD AGREEMENTS THEREUNDER EX-10.1
  3. FORM OF CONVERTIBLE NOTE PURCHASE AGREEMENT, BY AND AMONG CERO THERAPEUTICS, INC. AND THE PURCHASERS SIGNATORY THERETO, DATED MAY [ ], 2023 EX-10.19
  4. CONSENT OF WOLF & CO., INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM EX-23.1
  5. CONSENT OF CITRIN COOPERMAN & COMPANY LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. EX-23.3
  6. CONSENT OF DANIEL COREY TO BE NAMED AS A DIRECTOR EX-99.1
  7. FILING FEE TABLE EX-FILING FEES
  8. XBRL SCHEMA FILE EX-101.SCH
  9. XBRL CALCULATION FILE EX-101.CAL
  10. XBRL DEFINITION FILE EX-101.DEF
  11. XBRL LABEL FILE EX-101.LAB
  12. XBRL PRESENTATION FILE EX-101.PRE

On sec.gov